Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Ticlopidine

An antiplatelet drug of the thienopyridine family that irreversibly blocks the platelet P2Y12 receptor. Discovered in France in the 1970s and marketed from 1978, it has been used to prevent stroke and thrombosis. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.

Did you know?The team of Fernand Eloy and Jean-Pierre Maffrand was looking for a new anti-inflammatory: instead the molecule proved to be a strong antiplatelet agent, and it was the forerunner that led to clopidogrel.

TiclopidineGo to the active ingredient →
TiclopidineActive ingredientTiclopidineCat. No. P-T114-001CAS 55142-85-3

EDQM standards 1

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.